Russell Investments Group, Ltd. Nkarta, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$5.27 - $10.82 $12,574 - $25,816	2,386 Added 6448.65%	2,423 $14,000
Q1 2024 May 08, 2024	BUY	$5.59 - $15.71 $206 - $581	37 New	37 $0
Q3 2023 Nov 13, 2023	BUY	$1.39 - $2.29 $1,384 - $2,280	996 New	996 $1,000
Q1 2022 May 05, 2022	SELL	$8.66 - $14.99 $360,567 - $624,123	-41,636 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$12.79 - $26.88 $10,730 - $22,552	839 Added 2.06%	41,636 $639,000
Q3 2021 Nov 08, 2021	BUY	$26.67 - $38.76 $1.09 Million - $1.58 Million	40,797 New	40,797 $1.13 Million

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.